Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Anbio Biotechnology (NNNN) had Current Liabilities of $0.09M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$8.65M |
|
$6.40M |
|
$1.10M |
|
$7.54M |
|
$2.88M |
|
$5.77M |
|
$0.64M |
|
$6.40M |
|
$6.40M |
|
$6.40M |
|
$6.40M |
|
$6.40M |
|
$6.40M |
|
$5.77M |
|
$5.77M |
|
43.67M |
|
43.67M |
|
$0.15 |
|
$0.15 |
|
| Balance Sheet Financials | |
$30.24M |
|
-- |
|
-- |
|
$30.24M |
|
|
Current Liabilities |
$0.09M |
-- |
|
-- |
|
$0.09M |
|
$30.16M |
|
$30.16M |
|
$30.16M |
|
143.89M |
|
| Cash Flow Statement Financials | |
$-6.74M |
|
$-4.20M |
|
$6.95M |
|
$11.76M |
|
$7.77M |
|
$-3.99M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
344.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.24% |
|
66.70% |
|
66.70% |
|
66.70% |
|
74.06% |
|
74.06% |
|
$-6.74M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
-- |
|
2.37 |
|
154.33 |
|
21.24% |
|
21.24% |
|
21.17% |
|
21.24% |
|
$0.21 |
|
$-0.15 |
|
$-0.15 |
|